These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 26746654)
1. Survival advantage of lymphadenectomy in endometrial cancer. Eggemann H; Ignatov T; Kaiser K; Burger E; Costa SD; Ignatov A J Cancer Res Clin Oncol; 2016 May; 142(5):1051-60. PubMed ID: 26746654 [TBL] [Abstract][Full Text] [Related]
2. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy. Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094 [TBL] [Abstract][Full Text] [Related]
3. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Todo Y; Kato H; Kaneuchi M; Watari H; Takeda M; Sakuragi N Lancet; 2010 Apr; 375(9721):1165-72. PubMed ID: 20188410 [TBL] [Abstract][Full Text] [Related]
4. The effect of introducing pelvic lymphadenectomy on survival and recurrence rates in Danish endometrial cancer patients at high risk: a Danish Gynecological Cancer Group study. Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M Int J Gynecol Cancer; 2019 Jan; 29(1):68-76. PubMed ID: 30640686 [TBL] [Abstract][Full Text] [Related]
5. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer. Alay I; Turan T; Ureyen I; Karalok A; Tasci T; Ozfuttu A; Kose MF; Tulunay G Pathol Oncol Res; 2015 Jul; 21(3):803-10. PubMed ID: 25564000 [TBL] [Abstract][Full Text] [Related]
6. Analysis of patients with stage IIIC endometrial cancer. Turan T; Ureyen I; Duzguner I; Ozkaya E; Tasci T; Karalok A; Boran N; Kose MF; Tulunay G Int J Gynecol Cancer; 2014 Jul; 24(6):1033-41. PubMed ID: 24905617 [TBL] [Abstract][Full Text] [Related]
7. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers. Venigalla S; Chowdhry AK; Shalowitz DI Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination. Altay A; Toptas T; Dogan S; Simsek T; Pestereli E Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255 [TBL] [Abstract][Full Text] [Related]
9. Survival impact of lymphadenectomy stratified by nodal metastatic probability in endometrial cancer. Koskas M; Fournier M; Luton D; Darai E; Rouzier R Ann Surg Oncol; 2014 Jul; 21(7):2376-82. PubMed ID: 24590435 [TBL] [Abstract][Full Text] [Related]
10. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer. Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283 [TBL] [Abstract][Full Text] [Related]
11. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging. Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247 [TBL] [Abstract][Full Text] [Related]
12. Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group. Poupon C; Bendifallah S; Ouldamer L; Canlorbe G; Raimond E; Hudry N; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Levêque J; Lavoue V Ann Surg Oncol; 2017 Jun; 24(6):1667-1676. PubMed ID: 28008573 [TBL] [Abstract][Full Text] [Related]
14. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study. Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110 [TBL] [Abstract][Full Text] [Related]
15. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network. Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880 [TBL] [Abstract][Full Text] [Related]
16. Patterns of recurrence in endometrial cancer patients at risk of lymph node metastasis or recurrence according to extent of lymphadenectomy. Kim HJ; Kim TJ; Song T; Kim MK; Lee YY; Choi CH; Lee JW; Bae DS; Kim BG Int J Gynecol Cancer; 2012 May; 22(4):611-6. PubMed ID: 22398712 [TBL] [Abstract][Full Text] [Related]
17. To what extent should para-aortic lymphadenectomy be carried out for surgically staged endometrial cancer? Dogan NU; Gungor T; Karsli F; Ozgu E; Besli M Int J Gynecol Cancer; 2012 May; 22(4):607-10. PubMed ID: 22546819 [TBL] [Abstract][Full Text] [Related]
18. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study. Kikuchi A; Yanase T; Sasagawa M; Honma S J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906 [TBL] [Abstract][Full Text] [Related]
19. Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis. Petousis S; Christidis P; Margioula-Siarkou C; Papanikolaou A; Dinas K; Mavromatidis G; Guyon F; Rodolakis A; Vergote I; Kalogiannidis I Arch Gynecol Obstet; 2020 Jul; 302(1):249-263. PubMed ID: 32468162 [TBL] [Abstract][Full Text] [Related]
20. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period". Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]